LycoRed Ltd.   Report issue

For profit Phase 2
Founded: Orange NJ United States (1995)
Status: No NME R&D (1995)

Organization Overview

First Clinical Trial
2008
NCT00637858
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

LycoRed Ltd.